{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:06:42Z","timestamp":1790690802866,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["ISRM\/12(22)\/2019"],"award-info":[{"award-number":["ISRM\/12(22)\/2019"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["2019\\u20130370"],"award-info":[{"award-number":["2019\\u20130370"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.compbiomed.2025.110551","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T23:37:36Z","timestamp":1749598656000},"page":"110551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["3D-QSAR based computational screening of potent ligands against L-type calcium channel (LTCC) protein structure for iron overload in \u03b2-thalassemia"],"prefix":"10.1016","volume":"194","author":[{"given":"Piyush Kumar","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna Kumar","family":"Ojha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4544-3596","authenticated-orcid":false,"given":"Ajay Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2025.110551_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173513","article-title":"L-type calcium channel blockers decrease the iron overload-mediated oxidative stress in renal epithelial cells by reducing iron accumulation","volume":"886","author":"Sun","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110551_bib2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/15353702221076397","article-title":"Iron overload cardiomyopathy: using the latest evidence to inform future applications","volume":"247","author":"Kumfu","year":"2022","journal-title":"Exp. Biol. Med."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110551_bib3","first-page":"213","article-title":"Iron overload thalassemic cardiomyopathy: iron status assessment and mechanisms of mechanical and electrical disturbance due to iron toxicity","volume":"25","author":"Lekawanvijit","year":"2009","journal-title":"Can. J. Cardiol."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110551_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/asheducation-2017.1.265","article-title":"Iron overload in thalassemia: different organs at different rates","volume":"2017","author":"Taher","year":"2017","journal-title":"Hematol. Am. Soc. Hematol. Educ. Progr."},{"key":"10.1016\/j.compbiomed.2025.110551_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116408","article-title":"The inhibitory effect of escitalopram on mouse detrusor contractility: the role of L-type calcium channels","volume":"461","author":"Engin","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110551_bib6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/03630269.2020.1853561","article-title":"Calcium Channel blockers in conjunction with standard iron-chelating agents for \u03b2-thalassemia major: systematic literature search","volume":"44","author":"Alali","year":"2020","journal-title":"Hemoglobin"},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110551_bib7","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/ejh.13919","article-title":"Efficacy and safety of calcium channel blockers in preventing cardiac siderosis in thalassemia patients: an updated meta-analysis with trial sequential analysis","volume":"110","author":"Soliman","year":"2023","journal-title":"Eur. J. Haematol."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110551_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29564","article-title":"Comparison of the effects of calcium channel blockers plus iron chelation therapy versus chelation therapy only on iron overload in children and young adults with transfusion-dependent thalassemia: a randomized double-blind placebo-controlled trial","volume":"69","author":"Gupta","year":"2022","journal-title":"Pediatr. Blood Cancer"},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110551_bib9","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.bbadis.2018.08.030","article-title":"Role of iron metabolism in heart failure: from iron deficiency to iron overload","volume":"1865","author":"Zhang","year":"2019","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110551_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0112915","article-title":"Iron overload and apoptosis of HL-1 cardiomyocytes: effects of calcium channel blockade","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110551_bib11","first-page":"CD011626","article-title":"Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia","volume":"7","author":"Sadaf","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110551_bib12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00109-005-0029-x","article-title":"Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy","volume":"84","author":"Oudit","year":"2006","journal-title":"J. Mol. Med."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110551_bib13","first-page":"1","article-title":"The influence of cardiovascular medications on iron metabolism in patients with heart failure","volume":"55","author":"Sirbu","year":"2019","journal-title":"M\u00e9d. Sur"},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110551_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4330\/wjc.v3.i7.215","article-title":"Calcium channels and iron uptake into the heart","volume":"3","author":"Chattipakorn","year":"2011","journal-title":"World J. Cardiol."},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110551_bib15","first-page":"1009","article-title":"Effects of iron overload on cardiac calcium regulation: translational insights into mechanisms and management of a global epidemic","volume":"32","author":"Khamseekaew","year":"2016","journal-title":"Can. J. Cardiol."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110551_bib16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1600-0609.2012.01782.x","article-title":"Voltage-gated Ca2+ channels as key mediators of iron-transport and iron-overload cardiomyopathy: L-type vs. T-type Ca+ channels","volume":"88","author":"Das","year":"2012","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.compbiomed.2025.110551_bib17","doi-asserted-by":"crossref","DOI":"10.1177\/26348535221103560","article-title":"A review of iron overload in beta-thalassemia major, and a discussion on alternative potent iron chelation targets","volume":"16","author":"Yadav","year":"2022","journal-title":"Plasmatology"},{"issue":"16","key":"10.1016\/j.compbiomed.2025.110551_bib18","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.1080\/07391102.2021.1899049","article-title":"Ligand based 3D-QSAR model, pharmacophore, molecular docking and ADME to identify potential fibroblast growth factor receptor 1 inhibitors","volume":"40","author":"Huang","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110551_bib19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jmgm.2010.07.007","article-title":"Docking-enabled pharmacophore model for histone deacetylase 8 inhibitors and its application in anti-cancer drug discovery","volume":"29","author":"Sundarapandian","year":"2010","journal-title":"J. Mol. Graph. Model."},{"issue":"12","key":"10.1016\/j.compbiomed.2025.110551_bib20","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1016\/j.ejmech.2009.07.018","article-title":"Discovery of potential ZAP-70 kinase inhibitors: pharmacophore design, database screening and docking studies","volume":"44","author":"Sanam","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2025.110551_bib21","doi-asserted-by":"crossref","first-page":"909111","DOI":"10.3389\/fcimb.2022.909111","article-title":"3D-QSAR-Based pharmacophore modeling, virtual screening, and molecular dynamics simulations for the identification of spleen tyrosine kinase inhibitors","volume":"12","author":"Kumar","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.compbiomed.2025.110551_bib22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.csbj.2019.02.006","article-title":"Ligand-based pharmacophore modeling, virtual screening and molecular docking studies for discovery of potential topoisomerase I inhibitors","volume":"17","author":"Pal","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.compbiomed.2025.110551_bib23","doi-asserted-by":"crossref","first-page":"812148","DOI":"10.1155\/2014\/812148","article-title":"Ligand based pharmacophore modeling and virtual screening studies to design novel HDAC2 inhibitors","volume":"2014","author":"Kandakatla","year":"2014","journal-title":"Adv. Bioinformatics"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110551_bib24","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/0045-6535(95)00119-S","article-title":"Assessment of developmental toxicity potential of chemicals by quantitative structure-toxicity relationship models","volume":"31","author":"Gomba","year":"1995","journal-title":"Chemosphere"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110551_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/1098-2280(2001)37:1<55::AID-EM1006>3.0.CO;2-5","article-title":"Evaluation of the TOPKAT system for predicting the carcinogenicity of chemicals","volume":"37","author":"Prival","year":"2001","journal-title":"Environ. Mol. Mutagen."},{"issue":"0","key":"10.1016\/j.compbiomed.2025.110551_bib26","first-page":"1","article-title":"Hydroxamic acid derivatives as selective HDAC3 inhibitors: computer-aided drug design strategies","volume":"0","author":"Patel","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110551_bib27","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1021\/ci6004299","article-title":"Validation studies of the site-directed docking program LibDock","volume":"47","author":"Rao","year":"2007","journal-title":"J. Chem. Inf. Model."},{"issue":"Database issue","key":"10.1016\/j.compbiomed.2025.110551_bib28","doi-asserted-by":"crossref","first-page":"D198","DOI":"10.1093\/nar\/gkl999","article-title":"BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities","volume":"35","author":"Liu","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.110551_bib29","series-title":"Dassault Syst\u00e8mes BIOVIA Discovery Studio Visualizer v19.1.0.18287","author":"Dassault Syst\u00e8mes","year":"2019"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110551_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"ZINC \u2212 A free database of commercially available compounds for virtual screening","volume":"45","author":"Irwin","year":"2005","journal-title":"J. Chem. Inf. Model."},{"issue":"Database issue","key":"10.1016\/j.compbiomed.2025.110551_bib31","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110551_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T","article-title":"High throughput docking for library design and library prioritization","volume":"43","author":"Diller","year":"2001","journal-title":"Proteins"},{"issue":"13","key":"10.1016\/j.compbiomed.2025.110551_bib33","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/jcc.10306","article-title":"Detailed analysis of grid-based molecular docking: a case study of CDOCKER-A CHARMm-based MD docking algorithm","volume":"24","author":"Wu","year":"2003","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2025.110551_bib34","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1063\/1.439486","article-title":"Molecular dynamics simulations at constant pressure and\/or temperature","volume":"72","author":"Andersen","year":"1980","journal-title":"J. Chem. Phys."},{"issue":"January","key":"10.1016\/j.compbiomed.2025.110551_bib35","first-page":"252","article-title":"Gromacs: a parallel computer for molecular dynamics simulations \u2013 ScienceOpen","volume":"92","author":"Bekker","year":"1993","journal-title":"Phys. Comput."},{"key":"10.1016\/j.compbiomed.2025.110551_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.compbiomed.2025.110551_bib37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/00268970110089108","article-title":"A molecular dynamics method for simulations in the canonical ensemble","volume":"100","author":"Nos\u00e9","year":"1984","journal-title":"Mol. Phys."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110551_bib38","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"12","key":"10.1016\/j.compbiomed.2025.110551_bib39","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1021\/ci300363c","article-title":"Automation of the CHARMM general force field (CGenFF) I: bond perception and atom typing","volume":"52","author":"Vanommeslaeghe","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2025.110551_bib40","series-title":"Computer Simulation of Liquids","author":"Allen","year":"2017"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110551_bib41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/thalassrep13010005","article-title":"Cardiovascular complications in \u03b2-thalassemia: getting to the heart of it","volume":"13","author":"Akiki","year":"2023","journal-title":"Thalass. Reports"},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110551_bib42","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/ajh.25103","article-title":"The effect of iron chelation therapy on overall survival in sickle cell disease and \u03b2-thalassemia: a systematic review","volume":"93","author":"Ballas","year":"2018","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110551_bib43","article-title":"Calcium channel blockers use in iron overload for thalassemias with regular blood transfusions","volume":"35","author":"Sae-lim","year":"2021","journal-title":"Reg. 11 Med. J."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525009023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525009023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:20:30Z","timestamp":1790688030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482525009023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":43,"alternative-id":["S0010482525009023"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110551","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3D-QSAR based computational screening of potent ligands against L-type calcium channel (LTCC) protein structure for iron overload in \u03b2-thalassemia","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110551"}}